Jefferies Financial Group’s Quest Diagnostics DGX Stock Holding History

Jefferies Financial Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.56M	Sell	33,473 -7,646	-19%	-$1.49M	0.04%	288
2025 Q4	$7.14M	Buy	41,119 +19,683	+92%	+$3.58M	0.04%	409
2025 Q3	$4.09M	Sell	21,436 -4,024	-16%	-$714K	0.02%	430
2025 Q2	$4.57M	Sell	25,460 -141	-0.6%	-$24.5K	0.04%	322
2025 Q1	$4.33M	Buy	25,601 +701	+3%	+$115K	0.04%	331
2024 Q4	$3.76M	Buy	24,900 +3,627	+17%	+$564K	0.02%	454
2024 Q3	$3.3M	Sell	21,273 -38,032	-64%	-$5.68M	0.02%	427
2024 Q2	$8.12M	Buy	59,305 +3,307	+6%	+$453K	0.09%	184
2024 Q1	$7.45M	Buy	55,998 +49,198	+724%	+$6.38M	0.07%	210
2023 Q4	$938K	Sell	6,800 -2,400	-26%	-$316K	0.01%	988
2023 Q3	$1.12M	Buy	9,200 +5,854	+175%	+$780K	0.01%	793
2023 Q2	$470K	Buy	+3,346	New	+$461K	﹤0.01%	1196
2023 Q1	–	Sell	-5,170	Closed	-$809K	–	1704
2022 Q4	$809K	Buy	+5,170	New	+$743K	0.01%	925

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Jefferies Financial Group's DGX Position: Q1 2026 in Review

Jefferies Financial Group reduced its Quest Diagnostics (DGX) stake by 19% in Q1 2026, selling an estimated $1.49M and leaving 33,473 shares worth $6.56M. The position accounts for 0.04% of the portfolio, ranked #288.

Jefferies Financial Group first reported a position in DGX in Q4 2022 and has held it in 13 quarters since. The position peaked at $8.12M in Q2 2024. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Jefferies Financial Group held 33,473 shares of Quest Diagnostics worth $6.56M as of Q1 2026.
Jefferies Financial Group sold 7,646 Quest Diagnostics shares in Q1 2026, an estimated $1.49M.
Quest Diagnostics made up 0.04% of Jefferies Financial Group's portfolio in Q1 2026, its #288 holding.
Jefferies Financial Group first reported a position in Quest Diagnostics in Q4 2022 and has held it in 13 quarters since.
Jefferies Financial Group's Quest Diagnostics position peaked at $8.12M in Q2 2024.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.